Yttrium (90y) Colloid Cis Bio International

Yttrium (90Y) Citrate is a radiopharmaceutical colloid used for intraarticular therapy, particularly in joint pain management. This EU-sourced treatment targets localized inflammation with targeted radiation. Ideal for patients seeking localized pain relief solutions. Short version: radiopharmaceutical colloid for intraarticular therapy in joint pain management.

Yttrium (90Y) Citrate is primarily used to manage joint pain associated with conditions like rheumatoid arthritis or osteoarthritis. It delivers localized radiation to inflamed synovial tissue, reducing pain and inflammation. Patients often ask, 'what is Yttrium (90Y) Citrate used for' when seeking targeted relief for persistent joint discomfort. This treatment is designed for intraarticular administration.

Yttrium (90Y) Citrate works by emitting beta radiation to target inflamed joint tissues, helping to reduce pain and swelling over time. The effects are typically gradual, with noticeable improvements in joint mobility and comfort. Patients may experience mild discomfort at the injection site, which is common with intraarticular procedures.

Handling Yttrium (90Y) Citrate requires strict adherence to radiation safety protocols due to its radioactive properties. It should only be administered by trained healthcare professionals in controlled settings. Patients should avoid close contact with others for a specified period post-treatment to minimize radiation exposure to bystanders.

Yttrium (90Y) Citrate does not interact with medications in the traditional sense, but its effects are localized to the joint space. Patients should inform their healthcare provider about all current medications to ensure compatibility with intraarticular procedures. Alcohol and certain supplements may be restricted post-treatment to avoid complications.